RJFSA
ABMD

Raymond James Financial Services Advisors’s Abiomed Inc ABMD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,150
Closed -$283K – 3423
2022
Q3 		$283K Sell
1,150
-232
-17% -$62.6K ﹤0.01% 2606
2022
Q2 		$342K Buy
1,382
+211
+18% +$56.9K ﹤0.01% 2501
2022
Q1 		$388K Sell
1,171
-16,961
-94% -$5.22M ﹤0.01% 2526
2021
Q4 		$6.51M Buy
18,132
+592
+3% +$200K 0.01% 885
2021
Q3 		$5.71M Buy
17,540
+9,444
+117% +$3.2M 0.01% 900
2021
Q2 		$2.53M Buy
8,096
+467
+6% +$143K 0.01% 1343
2021
Q1 		$2.43M Buy
7,629
+1,127
+17% +$361K 0.01% 1276
2020
Q4 		$2.11M Sell
6,502
-14,199
-69% -$3.93M 0.01% 1263
2020
Q3 		$5.74M Buy
20,701
+14,820
+252% +$4.27M 0.02% 703
2020
Q2 		$1.42M Buy
5,881
+1,061
+22% +$213K ﹤0.01% 1286
2020
Q1 		$700K Buy
4,820
+721
+18% +$120K ﹤0.01% 1376
2019
Q4 		$699K Sell
4,099
-806
-16% -$149K ﹤0.01% 1763
2019
Q3 		$873K Sell
4,905
-859
-15% -$186K ﹤0.01% 1540
2019
Q2 		$1.5M Sell
5,764
-2,876
-33% -$763K 0.01% 1258
2019
Q1 		$2.47M Buy
8,640
+2,832
+49% +$941K 0.01% 963
2018
Q4 		$1.89M Sell
5,808
-2,499
-30% -$868K 0.01% 930
2018
Q3 		$3.74M Sell
8,307
-5,252
-39% -$2.07M 0.02% 763
2018
Q2 		$5.55M Buy
13,559
+3,347
+33% +$1.21M 0.03% 564
2018
Q1 		$2.97M Buy
10,212
+6,617
+184% +$1.68M 0.02% 765
2017
Q4 		$674K Buy
3,595
+1,682
+88% +$314K ﹤0.01% 1535
2017
Q3 		$323K Sell
1,913
-147
-7% -$22.2K ﹤0.01% 1980
2017
Q2 		$295K Sell
2,060
-780
-27% -$105K ﹤0.01% 1997
2017
Q1 		$356K Sell
2,840
-945
-25% -$110K ﹤0.01% 1793
2016
Q4 		$426K Sell
3,785
-9,072
-71% -$1.05M ﹤0.01% 1616
2016
Q3 		$1.65M Sell
12,857
-15,605
-55% -$1.87M 0.01% 846
2016
Q2 		$3.11M Sell
28,462
-4,079
-13% -$406K 0.03% 549
2016
Q1 		$3.08M Buy
+32,541
New +$2.75M 0.04% 466

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raymond James Financial Services Advisors's ABMD Position: Q4 2022 in Review

Raymond James Financial Services Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,150 shares — an estimated $283K sold.

Raymond James Financial Services Advisors first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $6.51M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Raymond James Financial Services Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,150 Abiomed Inc shares in Q4 2022, an estimated $283K.
  • Raymond James Financial Services Advisors first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Raymond James Financial Services Advisors's Abiomed Inc position peaked at $6.51M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.